logo
Lilavati Trust files  ₹1,000 crore defamation suit against HDFC Bank CEO Sashidhar Jagdishan over ‘malicious' statement

Lilavati Trust files ₹1,000 crore defamation suit against HDFC Bank CEO Sashidhar Jagdishan over ‘malicious' statement

Mint4 hours ago

In a fresh twist in the HDFC Bank vs Lilavati Trust row, the Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a ₹ 1,000 crore civil defamation lawsuit against HDFC Bank MD and CEO Sashidhar Jagdishan.
The Lilavati Trust has accused the HDFC Bank CEO of making a series of 'malicious, false and defamatory' statements against it and its permanent trustee, Prashant Mehta.
'The Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a ₹ 1,000 crore civil defamation lawsuit against Mr. Sashidhar Jagdishan, Managing Director & CEO of HDFC Bank, over a series of malicious, false, and defamatory statements made against the Trust and its Permanent Trustee, Mr. Prashant Mehta,' the Trust said in a statement.
The Lilavati Hospital in Mumbai is overseen by the Lilavati Kirtilal Mehta Medical Trust.
The Trust accused Jagdishan of undertaking a 'coordinated campaign to malign its reputation and obstruct its operations as a public charitable institution'.
In addition to the ₹ 1,000 crore defamation suit, the Lilavati Trust has also filed a criminal complaint before the Metropolitan Magistrate of Girgaon, Maharashtra.
The magistrate has issued a notice to HDFC Bank CEO Sashidhar Jagdishan, its spokesperson, and the corporate communication head.
The Trust said that the criminal complaint and subsequent notice mark 'a significant step in holding the HDFC CEO accountable for what the Trust alleges is a deliberate and sustained smear campaign'.
The Lilavati Trust said its actions were not retaliatory, 'but are in response to a sustained effort to discredit a respected charitable institution and its founding family without any supporting documentation or conclusive evidence from HDFC Bank to validate its claims'.
Denying HDFC Bank's allegations, it said, 'The Trust and Prashant Mehta are not connected to the affairs of Splendour Gems in any manner whatsoever as fraudulently espoused by the CEO of HDFC.'
Earlier this week, HDFC Bank CEO Sashidhar Jagdishan moved the Bombay High Court, seeking the quashing of an FIR filed by the Lilavati Trust.
The FIR stems from a magistrate court's order, directing the police to investigate the charges of alleged financial fraud.
The Lilavati Trust has alleged in the complaint that of the ₹ 14.42 crore misappropriated by its trustees, ₹ 2.05 crore was received by Jagdishan. It also claimed that the offer of ₹ 1.5 crore disguised as Corporate Social Responsibility (CSR) funds to hospital staff shows the intent to destroy evidence and obstruct justice.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

HDB Financial sets Rs 700–740 price band for Rs 12,500-crore IPO
HDB Financial sets Rs 700–740 price band for Rs 12,500-crore IPO

New Indian Express

time38 minutes ago

  • New Indian Express

HDB Financial sets Rs 700–740 price band for Rs 12,500-crore IPO

MUMBAI: HDB Financial Services, a retail-focused NBFC owned by HDFC Bank, has set a price band of Rs 700–740 for its Rs 12,500-crore IPO, marking a steep premium over face value but a sharp discount to grey market rates. At the upper end of the price band, the company will be valued at USD 7.5 billion, compared to the grey market valuation of USD 10.5 billion. The mega issue, the largest from the NBFC space, comprises a Rs 2,500 crore fresh issue of shares of Rs 10 face value and Rs 10,000 crore in offer-for-sale by parent HDFC Bank, which currently holds 94.3% of the company. The remaining 5.7% shares are held by the employees trust and employees through ESOPs, Chief Financial Officer Jaykumar Shah told TNIE at the press meet announcing the issue. Post-issue, HDFC Bank will continue to hold 75% of the equity. HDB Financial, founded in 2008, has been growing rapidly. In FY25, its loan book, 73% of which is secured, crossed the Rs 1-trillion mark, from which it earned a net income of Rs 2,180 crore, up 29% from the previous fiscal. However, asset quality remains a concern, with gross NPAs at 2.3% and net NPAs at 1% of assets. The IPO is also intended to comply with the RBI's October 2022 directive requiring large NBFCs to go public by September 2025. When asked about launching the IPO during a choppy market and at a discount to the grey market price, CEO Ramesh Ganesh said the valuation was arrived at after discussions with investors and bankers. 'We've been doing roadshows for quite some time now, meeting investors globally and locally. We believe the value is derived by talking to investors and bankers, and we worked with them to arrive at the value,' Ramesh said.

Lilavati Trust Slaps Rs 1,000-Crore Defamation Suit On HDFC Bank CEO Sashidhar Jagdishan; Details Here
Lilavati Trust Slaps Rs 1,000-Crore Defamation Suit On HDFC Bank CEO Sashidhar Jagdishan; Details Here

News18

time2 hours ago

  • News18

Lilavati Trust Slaps Rs 1,000-Crore Defamation Suit On HDFC Bank CEO Sashidhar Jagdishan; Details Here

The Lilavati Kirtilal Mehta Medical Trust filed a Rs 1,000 crore defamation lawsuit and a criminal complaint against HDFC Bank CEO Sashidhar Jagdishan for alleged false statements. In an escalation of the ongoing dispute, the Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a Rs 1,000 crore civil defamation lawsuit against HDFC Bank Managing Director & CEO Sashidhar Jagdishan, accusing him of making 'malicious, false and defamatory" statements against the Trust and its permanent trustee Prashant Mehta. In an official statement, the Trust said, 'The Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has filed a Rs 1,000 crore civil defamation lawsuit against Mr. Sashidhar Jagdishan, Managing Director & CEO of HDFC Bank, over a series of malicious, false, and defamatory statements made against the Trust and its Permanent Trustee, Mr. Prashant Mehta." The Lilavati Hospital, one of Mumbai's best-known healthcare institutions, operates under the aegis of the LKMM Trust. 'Coordinated Smear Campaign' The Trust alleged that Jagdishan launched a 'coordinated campaign to malign its reputation and obstruct its operations as a public charitable institution." In a parallel move, the Trust has also filed a criminal complaint before the Metropolitan Magistrate of Girgaon, Maharashtra. The court has issued notices to Sashidhar Jagdishan, HDFC Bank's spokesperson, and its corporate communication head. The Trust described the legal action as a vital step forward. 'The criminal complaint and subsequent notice mark a significant step in holding the HDFC CEO accountable for what the Trust alleges is a deliberate and sustained smear campaign," it said. The Trust further clarified that the legal action is not retaliatory: 'But are in response to a sustained effort to discredit a respected charitable institution and its founding family without any supporting documentation or conclusive evidence from HDFC Bank to validate its claims." FIR and Financial Fraud Allegations Denying all allegations linking it to a company under scrutiny, the Trust said, 'The Trust and Prashant Mehta are not connected to the affairs of Splendour Gems in any manner whatsoever as fraudulently espoused by the CEO of HDFC." In response, earlier this week, HDFC Bank MD and CEO Sashidhar Jagdishan approached the Bombay High Court, seeking quashing of the FIR registered against him based on the financial fraud allegations made by the Lilavati Trust, which oversees the Mumbai-based Lilavati Hospital. The plea was mentioned before the court on Wednesday and will be heard in due course of time. The FIR stems from a magistrate court's order, directing the police to investigate the charges of alleged financial fraud. The Lilavati Kirtilal Mehta Medical Trust (LKMM Trust) has alleged in the complaint that of the Rs 14.42 crore misappropriated by its trustees, Rs 2.05 crore were received by Jagdishan. It also claimed that the offer of Rs 1.5 crore disguised as Corporate Social Responsibility (CSR) funds to hospital staff shows the intent to destroy evidence and obstruct justice. Despite judicial findings and multiple complaints, HDFC Bank failed to act, violating Section 166 of the Companies Act and SEBI governance mandates, the Trust alleged. The bank, however, has denied the allegations, calling it 'outrageous and preposterous".

Dividend stocks! Vedanta, 31 others to go ex-date next week; full list here
Dividend stocks! Vedanta, 31 others to go ex-date next week; full list here

Business Standard

time3 hours ago

  • Business Standard

Dividend stocks! Vedanta, 31 others to go ex-date next week; full list here

Here is the complete list of stocks that will trade ex-dividend next week along with their key details SI Reporter New Delhi Dividend stocks: Shares of HDFC Bank, Vedanta, Hindustan Unilever, CARE Ratings, Cipla, Samvardhana Motherson International, and 26 others are expected to remain in the spotlight during the next week, Monday, June 23, 2025, to Friday, May 27, 2025, on account of their announcements of dividend for their respective shareholders. The other notable names to feature in the list include Bajaj Finserv, Dalmia Bharat, Swaraj Engines, Kansai Nerolac Paints, Aegis Logistics, Bajaj Holdings & Investment, Maharashtra Scooters, Kalpataru Projects International, and Sky Industries. The BSE data reveals that shares of these companies are slated to trade ex-dividend during this period. Notably, the ex-date refers to the day a stock begins trading without entitlement to the dividend, meaning investors must own the stock before this date to receive the payout. Among the highlighted companies, Mahindra Group's tractor engine maker Swaraj Engines has declared the highest dividend, announcing a final dividend of ₹104.50 per share. The company has also set Friday, June 27, 2025, as the record date for determining eligible shareholders for their participation in the said announcement. This is followed by Polycab India, which has announced a final dividend of ₹35 per share, also with the record date fixed as Tuesday, June 24, 2025, for the same. Among others, India's largest private sector lender, HDFC Bank, has announced to pay a dividend of ₹22 per share to its shareholders. Metal and mining major Vedanta will pay an interim dividend of ₹7 per share to its shareholders. Here is the complete list of stocks that will trade ex-dividend next week along with their key details: Company Ex-date Purpose Record date Dalmia Bharat June 23, 2025 Final Dividend - ₹5 June 23, 2025 Dynamic Cables June 23, 2025 Final Dividend - ₹0.50 June 23, 2025 Hindustan Unilever June 23, 2025 Final Dividend - ₹24 June 23, 2025 Kansai Nerolac Paints June 23, 2025 Final Dividend - ₹2.50 June 23, 2025 Kansai Nerolac Paints June 23, 2025 Special Dividend - ₹1.25 June 23, 2025 Kalpataru Projects International June 23, 2025 Final Dividend - ₹9 June 23, 2025 Samvardhana Motherson International June 23, 2025 Final Dividend - ₹0.35 June 23, 2025 Motherson Sumi Wiring India June 23, 2025 Final Dividend - ₹0.35 June 23, 2025 Pilani Investment and Industries Corporation June 23, 2025 Final Dividend - ₹15 June 23, 2025 Alkyl Amines Chemicals June 24, 2025 Final Dividend - ₹10 June 24, 2025 Polycab India June 24, 2025 Final Dividend - ₹35 June 24, 2025 Vedanta June 24, 2025 Interim Dividend - ₹7 June 24, 2025 Automobile Corporation of Goa June 25, 2025 Final Dividend - ₹20 June 25, 2025 Aegis Logistics June 25, 2025 Interim Dividend June 25, 2025 Quest Capital Markets June 25, 2025 Final Dividend - ₹2.50 June 25, 2025 Prime Securities June 26, 2025 Final Dividend - ₹1.50 June 26, 2025 Allied Blenders and Distillers June 27, 2025 Final Dividend - ₹3.60 June 27, 2025 Alufluoride June 27, 2025 Final Dividend - ₹3 June 27, 2025 Bajaj Finserv June 27, 2025 Final Dividend - ₹1 June 27, 2025 Bajaj Holdings & Investment June 27, 2025 Final Dividend - ₹28 June 27, 2025 Bharat Bhushan Finance & Commodity Brokers June 27, 2025 Final Dividend - ₹0.6 June 27, 2025 CARE Ratings June 27, 2025 Final Dividend - ₹11 June 27, 2025 Cipla June 27, 2025 Special Dividend - ₹3 June 27, 2025 Cipla June 27, 2025 Final Dividend - ₹13 June 27, 2025 HDFC Bank June 27, 2025 Dividend - ₹22 June 27, 2025 Jayant Agro Organics June 27, 2025 Dividend - ₹2.50 June 27, 2025 Maharashtra Scooters June 27, 2025 Special Dividend - ₹30 June 27, 2025 Maharashtra Scooters June 27, 2025 Final Dividend - ₹30 June 27, 2025 Rainbow Children's Medicare June 27, 2025 Final Dividend - ₹3 June 28, 2025 RPG Life Sciences June 27, 2025 Special Dividend - ₹4 June 27, 2025 RPG Life Sciences June 27, 2025 Final Dividend - ₹20 June 27, 2025 Sky Industries June 27, 2025 Final Dividend - ₹1 June 27, 2025 Swaraj Engines June 27, 2025 Final Dividend - ₹104.50 June 27, 2025 Syngene International June 27, 2025 Final Dividend - ₹1.25 June 27, 2025 Vaibhav Global June 27, 2025 Final Dividend - ₹1.50 June 28, 2025 Visaka Industries June 27, 2025 Final Dividend - ₹0.50 June 27, 2025

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store